Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-001623
Filing Date
2022-02-18
Accepted
2022-02-18 15:31:31
Documents
1
Period of Report
2022-02-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6420
  Complete submission text file 0001562180-22-001623.txt   7900
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121
Business Address
Stevens John Henry (Reporting) CIK: 0001835543 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 22652440